Cancer Vaccines

Goodwin Biotechnology and Menarini Announce the Successful Completion of Their Strategic US-Italian Cooperation to Fight Ovarian Cancer

Published in Medical Devices and Surgical Technology Week, July 29th, 2007

Goodwin Biotechnology, Inc. (GBI), of Plantation, Florida and Menarini Group, of Florence, Italy, have just announced the successful completion of a strategic co-operation for the manufacturing of the monoclonal antibody Abagovomab. This antibody is the active principle of the Menarini Group's groundbreaking ovarian cancer vaccine, now in phase III clinical studies around the world.

The monoclonal antibody, produced by GBI to standards fully compliant with both US and European requirements, will be used to kick off the initial phase of a multicenter clinical trial, known around the world as MIMOSA (Monoclonal antibody Immunotherapy for Malignancies of the Ovary by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2007-07-29)

More Articles from Medical Devices and Surgical Technology Week

Breast Cancer
MRI/MRS Combo Can Improve Early Detection of Breast Cancer
Diagnostic Assays
Study evaluates brain lesions of older patients
Drug Delivery
Nanobubbles Deliver Targeted Cancer Drugs Using Ultrasound
Heart Bypass Surgery
Engineered Blood Vessels Function like Native Tissue
Liver Cancer
Antibody retards growth and induces death in liver cancer cells
Macular Degeneration
Visual impairment associated with increased mortality risk
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry